Match tier Listed
Presence Current · Arkansas
Last published 2021
Sources OpenAlex · ORCID
Refreshed 2026-08-08

Jose C. Barreto

Researcher

Also affiliated: Texas Medical Center (1992); The University of Texas at Austin (1992–1996)

Unknown Researcher

4 h-index 6 pubs 154 cited

  • Animals
  • Rats
  • Ethanol
  • Female
  • Gastric Mucosa
  • Phosphoinositide-3 Kinase Inhibitors
  • Humans
  • Pyrimidines
  • Quinazolines
  • Transplantation, Heterologous
  • Carcinoma, Merkel Cell
  • Signal Transduction
  • Mice, SCID
  • Mice, Inbred NOD
  • Apoptosis

Biography and Research Information

OverviewAI-generated summary

Jose C. Barreto's research has focused on the analysis of medical data, including systematic reviews and meta-analyses of randomized controlled trials. His work has examined topics such as adjuvant transarterial chemoembolization following curative-intent hepatectomy for hepatocellular carcinoma and the morbidity associated with colectomy performed at the time of pancreatoduodenectomy, utilizing the Pancreas-Targeted American College of Surgeons NSQIP Database. Barreto has published a total of six papers, accumulating 152 citations and an h-index of 4. He has collaborated with several researchers at the University of Arkansas for Medical Sciences, including Lyle Burdine, Larkin Harris, Judy Bennett, and Camillo J. Barreto, each sharing one publication with him. Barreto remains recently active in his research endeavors.

Metrics

  • h-index: 4
  • Publications: 6
  • Citations: 154

Selected Publications

  • Morbidity of Colectomy at the Time of Pancreatoduodenectomy: An Analysis of the Pancreas-Targeted American College of Surgeons NSQIP Database (2021)
    Journal of the American College of Surgeons DOI OpenAlex
  • Adjuvant Transarterial Chemoembolization Following Curative-Intent Hepatectomy Versus Hepatectomy Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2021)
    Cancers 46 citations DOI OpenAlex
  • Inhibition of PI3K by copanlisib exerts potent antitumor effects on Merkel cell carcinoma cell lines and mouse xenografts (2020)
    Scientific Reports 27 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

8 Collaborators 1 Institution 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics